Bliss GVS Pharma

{
  "main_header": {
    "sid": 730684,
    "name": "Bliss GVS Pharma",
    "stock_name": "Bliss GVS Pharma",
    "full_name": "Bliss GVS Pharma Ltd",
    "name_url": "stocks-analysis/bliss-gvs-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "224.80",
    "chg": 18.35,
    "chgp": "8.89%",
    "dir": 1,
    "prev_price": "206.45",
    "mcapval": "2,305.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506197,
    "symbol": "BLISSGVS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE416D01022",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "1.07 cr",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bliss-gvs-pharma-730684-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Bliss GVS Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3909183",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BlissGVSPharmaL_technicaldot_3909183.png",
        "date": "2026-03-24 08:03:27",
        "description": "Bliss GVS Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a sharp day decline of 7.87%, the stock’s year-to-date return of 18.84% significantly outpaces the Sensex’s negative 14.70%, signalling underlying strength amid volatility."
      },
      {
        "title": "Bliss GVS Pharma Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-3898639",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BlissGVSPharmaL_mojoScore_3898639.png",
        "date": "2026-03-18 10:10:03",
        "description": "Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 Nov 2025. While the rating change occurred then, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Bliss GVS Pharma Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-by-marketsmojo-3878002",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BlissGVSPharmaL_mojoScore_3878002.png",
        "date": "2026-03-07 10:10:03",
        "description": "Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 12 Nov 2025. While this rating change occurred several months ago, the analysis and financial metrics presented here reflect the company’s current position as of 07 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bliss GVS Pharma Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-3852863",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BlissGVSPharmaL_mojoScore_3852863.png",
        "date": "2026-02-24 10:10:04",
        "description": "Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 12 Nov 2025. While this rating change occurred several months ago, the analysis and financial metrics presented here reflect the stock's current position as of 24 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Bliss GVS Pharma Gains 2.50%: Key Price Milestones and Market Momentum in February",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-gains-250-key-price-milestones-and-market-momentum-in-february-3849754",
        "imagepath": "",
        "date": "2026-02-21 15:04:38",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Feb:</strong> Stock opens at Rs.221.90 with a 1.88% gain</p>\n                    <p><strong>17 Feb:</strong> New 52-week high at Rs.244.05 and all-time high close at Rs.228.35</p>\n                    <p><strong>18 Feb:</strong> Minor correction with a 0.67% decline</p>\n                    <p><strong>19 Feb:</strong> Further dip amid Sensex decline, closing at Rs.226.60</p>\n                    <p><strong>20 Feb:</strong> Week closes at Rs.223.25, down 1.48% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.217.80</div></div>\n                  ..."
      },
      {
        "title": "Bliss GVS Pharma Ltd Hits New 52-Week High at Rs.244.05",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-new-52-week-high-at-rs24405-3844379",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BlissGVSPharmaL_priceRelatedfactors_3844379.png",
        "date": "2026-02-17 10:49:52",
        "description": "Bliss GVS Pharma Ltd has surged to a fresh 52-week high of Rs.244.05, marking a significant milestone in its stock performance. This new peak reflects robust momentum driven by sustained gains and strong market positioning within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Bliss GVS Pharma Ltd Stock Hits All-Time High at Rs.228.35",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-stock-hits-all-time-high-at-rs22835-3844095",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BlissGVSPharmaL_priceRelatedfactors_3844095.png",
        "date": "2026-02-17 10:11:03",
        "description": "Bliss GVS Pharma Ltd has reached a new all-time high of Rs.228.35, underscoring a remarkable phase of growth and robust market performance within the Pharmaceuticals & Biotechnology sector. This milestone reflects the company’s sustained upward trajectory amid a challenging market environment."
      },
      {
        "title": "Bliss GVS Pharma Gains 18.69%: 5 Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-gains-1869-5-key-factors-driving-the-surge-3839801",
        "imagepath": "",
        "date": "2026-02-14 15:09:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>09 Feb:</strong> New 52-week high of Rs.200</p>\n                    <p><strong>10 Feb:</strong> New 52-week high of Rs.211.8 and Q3 FY26 profit decline reported</p>\n                    <p><strong>11 Feb:</strong> New 52-week high of Rs.216.6</p>\n                    <p><strong>12 Feb:</strong> New 52-week high of Rs.217.1</p>\n                    <p><strong>13 Feb:</strong> Week closes at Rs.217.80 (-0.09%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.183.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><..."
      },
      {
        "title": "Bliss GVS Pharma Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-3837229",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BlissGVSPharmaL_mojoScore_3837229.png",
        "date": "2026-02-13 10:10:05",
        "description": "Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 12 Nov 2025. While this rating change occurred several months ago, the analysis below reflects the stock’s current fundamentals, returns, and financial metrics as of 13 February 2026, providing investors with an up-to-date perspective on the company’s position in the market."
      }
    ],
    "total": 310,
    "sid": "730684",
    "stock_news_url": "https://www.marketsmojo.com/news/bliss-gvs-pharma-730684"
  },
  "announcements": [
    {
      "caption": "Communication To The Shareholders Regarding Tax Deduction On Interim Dividend Declared On February 10 2026",
      "datetime": "17-Feb-2026",
      "details": "Please find enclosed herewith the communication to the shareholders regarding tax deduction on the interim dividend declared on February 10 2026.",
      "source": "BSE"
    },
    {
      "caption": "Rumour verification - Regulation 30(11)",
      "datetime": "13-Feb-2026",
      "details": "The Company wishes to clarify the news item that appeared in CNBC Awaaz today i.e. February 13 2026. Please find attached herewith Clarification Letter.",
      "source": "BSE"
    },
    {
      "caption": "Clarification On News Item Appearing In CNBC ????? On February 13 2026",
      "datetime": "13-Feb-2026",
      "details": "The Company wishes to clarify the news item that appeared in CNBC Awaaz today i.e. February 13 2026. Please find attached herewith the Clarification Letter.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has declared <strong>50%</strong> dividend, ex-date: 18 Feb 26",
          "dt": "2026-02-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08",
          "dt": "2008-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>3:5</strong> bonus issue, ex-date: 26 Sep 08",
          "dt": "2008-09-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bliss GVS Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-03-24 08:03:27

Bliss GVS Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a sharp day decline of 7.87%, the stock’s year-to-date return of 18.84% significantly outpaces the Sensex’s negative 14.70%, signalling underlying strength amid volatility.

Read full news article

Bliss GVS Pharma Ltd is Rated Hold

2026-03-18 10:10:03

Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 Nov 2025. While the rating change occurred then, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Bliss GVS Pharma Ltd is Rated Hold by MarketsMOJO

2026-03-07 10:10:03

Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 12 Nov 2025. While this rating change occurred several months ago, the analysis and financial metrics presented here reflect the company’s current position as of 07 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Bliss GVS Pharma Ltd is Rated Hold

2026-02-24 10:10:04

Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 12 Nov 2025. While this rating change occurred several months ago, the analysis and financial metrics presented here reflect the stock's current position as of 24 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Bliss GVS Pharma Gains 2.50%: Key Price Milestones and Market Momentum in February

2026-02-21 15:04:38

Key Events This Week

16 Feb: Stock opens at Rs.221.90 with a 1.88% gain

17 Feb: New 52-week high at Rs.244.05 and all-time high close at Rs.228.35

18 Feb: Minor correction with a 0.67% decline

19 Feb: Further dip amid Sensex decline, closing at Rs.226.60

20 Feb: Week closes at Rs.223.25, down 1.48% on the day

Week Open

Rs.217.80

...

Read full news article

Bliss GVS Pharma Ltd Hits New 52-Week High at Rs.244.05

2026-02-17 10:49:52

Bliss GVS Pharma Ltd has surged to a fresh 52-week high of Rs.244.05, marking a significant milestone in its stock performance. This new peak reflects robust momentum driven by sustained gains and strong market positioning within the Pharmaceuticals & Biotechnology sector.

Read full news article

Bliss GVS Pharma Ltd Stock Hits All-Time High at Rs.228.35

2026-02-17 10:11:03

Bliss GVS Pharma Ltd has reached a new all-time high of Rs.228.35, underscoring a remarkable phase of growth and robust market performance within the Pharmaceuticals & Biotechnology sector. This milestone reflects the company’s sustained upward trajectory amid a challenging market environment.

Read full news article

Bliss GVS Pharma Gains 18.69%: 5 Key Factors Driving the Surge

2026-02-14 15:09:17

Key Events This Week

09 Feb: New 52-week high of Rs.200

10 Feb: New 52-week high of Rs.211.8 and Q3 FY26 profit decline reported

11 Feb: New 52-week high of Rs.216.6

12 Feb: New 52-week high of Rs.217.1

13 Feb: Week closes at Rs.217.80 (-0.09%)

Week Open

Rs.183.50

Week Close

<...

Read full news article

Bliss GVS Pharma Ltd is Rated Hold

2026-02-13 10:10:05

Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 12 Nov 2025. While this rating change occurred several months ago, the analysis below reflects the stock’s current fundamentals, returns, and financial metrics as of 13 February 2026, providing investors with an up-to-date perspective on the company’s position in the market.

Read full news article

View All News